Pulmonary hypertension management in neonates

Area of Science:

• Cardiovascular Medicine
• Pulmonary Medicine
• Pharmacology

Background:

• Pulmonary hypertension (PH) management is multifaceted, involving support of cardiovascular and pulmonary function.
• Treatment aims to address the underlying cause of PH and prevent pulmonary vascular remodeling.
• Emerging strategies focus on the pulmonary vascular endothelium and its signaling pathways.

Purpose of the Study:

• To review the pathophysiology of pulmonary hypertension.
• To discuss the broad principles of PH management.
• To emphasize pharmacological therapies targeting the pulmonary vascular endothelium.

Main Methods:

• Literature review of pulmonary hypertension pathophysiology.
• Analysis of current PH management strategies.
• Focus on endothelial-targeted pharmacological interventions.

Main Results:

• Pulmonary hypertension necessitates a multi-pronged management approach.
• The pulmonary vascular endothelium is a key target for novel therapies.
• Pharmacological agents acting on the endothelium show promise.

Conclusions:

• Effective pulmonary hypertension management requires addressing multiple factors.
• Targeting the pulmonary vascular endothelium represents a significant advancement in PH therapy.
• Further research into endothelial-specific drugs is warranted for improved patient outcomes.